FIELD: medicine.
SUBSTANCE: invention concerns medicine, particularly oncology, and can be applied in radionuclide diagnostics of breast cancer. Method involves intravenous injection of TICI radioisotope with further scintigraphic examination over 10-15 and 180 minutes in planar mode with detection of radiopharmaceutical drug hyperfixation focus. Radioisotope 199TICI is used in the dosage of 270 MBq.
EFFECT: reduced radiation exposure of organism.
1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF RADIONUCLIDE DIAGNOSIS OF LUNG CANCER | 2008 |
|
RU2397704C2 |
| METHOD OF INDIVIDUAL PRE-RADIATION PREPARATION OF PATIENTS SUFFERING FROM BREAST CANCER | 2008 |
|
RU2377020C1 |
| METHOD FOR DIAGNOSING INTENSITY AND PREVALENCE OF INFLAMMATORY PROCESS IN CHILDREN SUFFERING TUBERCULOSIS | 2022 |
|
RU2823857C2 |
| METHOD OF PREDICTION OF SENSITIVITY TO ANTICANCER THERAPY OF HODGKIN'S LYMPHOMA | 2008 |
|
RU2393890C1 |
| METHOD OF DIAGNOSTICS OF REMOTE METASTASIS IN BREAST CANCER PATIENTS WITH HER2/NEU HYPEREXPRESSION | 2022 |
|
RU2800864C1 |
| METHOD FOR DIAGNOSTICS OF INFLAMMATORY PROCESS IN LUNGS AND IN INTRATHORACIC LYMPH NODES IN PATIENTS WITH SARCOIDOSIS | 2016 |
|
RU2638447C1 |
| METHOD OF BREAST CANCER DIAGNOSTICS WITH HER2/NEU HYPEREXPRESSION | 2022 |
|
RU2800818C1 |
| METHOD FOR ASSESSING THE REGIONAL SPREAD OF BREAST CANCER BY SINGLE-PHOTON EMISSION COMPUTER TOMOGRAPHY | 2017 |
|
RU2679302C1 |
| RADIONUCLIDE DIAGNOSTIC TECHNIQUE FOR BREAST CANCER WITH Her2/neu HYPEREXPRESSION | 2019 |
|
RU2720801C1 |
| METHOD OF DETERMINING FUNCTIONAL STATUS OF PATHWAY OF LYMPHOGENOUS METASTATIC SPREADING IN CASE OF CARCINOMA OF MAMMARY GLAND | 1991 |
|
RU2013999C1 |
